W. Marhoffer et al., EVIDENCE OF EXVIVO AND INVITRO IMPAIRED NEUTROPHIL OXIDATIVE BURST AND PHAGOCYTIC CAPACITY IN TYPE-1 DIABETES-MELLITUS, Diabetes research and clinical practice, 19(3), 1993, pp. 183-188
In this study neutrophil (PMN) oxidative burst activity was investigat
ed ex vivo and in vitro in comparison to the PMN-phagocytic functions
ingestion and bacterial killing in poorly-controlled type 1 diabetic p
atients. Luminol enhanced chemiluminescence in response to phorboleste
rs as a measure of oxidative burst was assessed in a parallel detectin
g microtiterplate luminometer in 40 poorly-controlled type 1 diabetic
subjects. PMN ingestion was measured with [H-3]thymidine-labelled Stap
hylococcus aureus in a kinetic radiometric assay. Microbicidal activit
y was determined by pure plate counting of surviving bacteria (colony
forming units, cfu) after defined pmn challenge. PMNs of type 1 diabet
ic subjects showed a highly significant reduction of peak CL response
in response to PMA compared to nondiabetic controls (P < 0.001) and PM
N ingestion (51.8 +/- 4.6%) and bacterial killing (28.6 +/- 3.20%) wer
e reduced as well (78.2 +/- 5.2% (IN) and 18.4 +/- 4.1% (BK), P < 0.01
, respectively). The in vitro data displayed impaired PMN oxidative bu
rst activity at glucose concentrations greater-than-or-equal-to 13.8.
mmol/l whereas PMN IN and BK were significantly reduced at glucose lev
els greater-than-or-equal-to 27.75 mmol/l. In the control group there
was a positive correlation of peak CL response and IN as well as BK (P
< 0.05); in type 1 diabetic patients this was also true, but did not
reach statistical significance. The data obtained in this study clearl
y demonstrated impaired PMN oxidative burst activity and markedly redu
ced ingestion and bacterial killing in type 1 diabetic patients ex viv
o and in vitro. These findings suggest inhibitory effects of elevated
glucose concentrations on various PMN-functions, which might be of cli
nical importance concerning impaired host defense.